# Novacyl Wuxi Pharmaceutical Co., Ltd. – FDA Inspection, Apr 14, 2016

Source: https://www.keypedia.com/records/fda_inspections/novacyl-wuxi-pharmaceutical-co-ltd/2229d702-8259-41c1-a77d-0cff43730a0f
Source feed: FDA_Inspections

> FDA inspection 965700 of Novacyl Wuxi Pharmaceutical Co., Ltd., April 14, 2016. Classification: Official Action Indicated (OAI). 3 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 965700
- Company Name: Novacyl Wuxi Pharmaceutical Co., Ltd.
- Inspection Date: 2016-04-14
- Classification: Official Action Indicated (OAI)
- Classification Code: OAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1029764 - 2017-09-15](https://www.keypedia.com/records/fda_inspections/novacyl-wuxi-pharmaceutical-co-ltd/1379cff2-3803-4f69-9cda-c9212000a332)
- [FDA Inspection 853505 - 2013-10-18](https://www.keypedia.com/records/fda_inspections/novacyl-wuxi-pharmaceutical-co-ltd/c61ca5ce-1363-4c25-b082-421ccc50aa4c)
- FDA Inspection 735469 - 2011-04-21

Company: https://www.keypedia.com/companies/novacyl-wuxi-pharmaceutical-co-ltd/df90cc11-f2af-4bb7-bf70-f32a8bcc4fb8

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
